Ovid Therapeutics Inc. Quarterly Return On Assets in % from Q3 2017 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Ovid Therapeutics Inc. quarterly/annual Return On Assets history and growth rate from Q3 2017 to Q3 2024.
  • Ovid Therapeutics Inc. Return On Assets for the quarter ending September 30, 2024 was -26.2 %, a 24.5% increase year-over-year.
  • Ovid Therapeutics Inc. annual Return On Assets for 2023 was -38.2 %, a 21.3% decline from 2022.
  • Ovid Therapeutics Inc. annual Return On Assets for 2022 was -31.5 %, a 155% decline from 2021.
  • Ovid Therapeutics Inc. annual Return On Assets for 2021 was 57.3 %.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -26.2 +8.48 +24.5% Jul 1, 2024 Sep 30, 2024
Q2 2024 -22.9 +9.89 +30.1% Apr 1, 2024 Jun 30, 2024
Q1 2024 -37.8 -5.67 -17.7% Jan 1, 2024 Mar 31, 2024
Q4 2023 -38.2 -6.7 -21.3% Oct 1, 2023 Dec 31, 2023
Q3 2023 -34.7 +3.06 +8.11% Jul 1, 2023 Sep 30, 2023
Q2 2023 -32.8 +2.53 +7.15% Apr 1, 2023 Jun 30, 2023
Q1 2023 -32.1 +2.1 +6.14% Jan 1, 2023 Mar 31, 2023
Q4 2022 -31.5 -88.8 -155% Oct 1, 2022 Dec 31, 2022
Q3 2022 -37.7 -106 -155% Jul 1, 2022 Sep 30, 2022
Q2 2022 -35.4 -114 -145% Apr 1, 2022 Jun 30, 2022
Q1 2022 -34.2 -136 -133% Jan 1, 2022 Mar 31, 2022
Q4 2021 57.3 +175 Oct 1, 2021 Dec 31, 2021
Q3 2021 68.7 +177 Jul 1, 2021 Sep 30, 2021
Q2 2021 78.2 +211 Apr 1, 2021 Jun 30, 2021
Q1 2021 102 +214 Jan 1, 2021 Mar 31, 2021
Q4 2020 -118 -18.6 -18.7% Oct 1, 2020 Dec 31, 2020
Q3 2020 -109 -1.26 -1.17% Jul 1, 2020 Sep 30, 2020
Q2 2020 -133 -41.5 -45.1% Apr 1, 2020 Jun 30, 2020
Q1 2020 -112 -25.5 -29.5% Jan 1, 2020 Mar 31, 2020
Q4 2019 -99.5 -18.1 -22.2% Oct 1, 2019 Dec 31, 2019
Q3 2019 -107 -40.1 -59.5% Jul 1, 2019 Sep 30, 2019
Q2 2019 -91.8 -36.3 -65.3% Apr 1, 2019 Jun 30, 2019
Q1 2019 -86.5 -39.6 -84.7% Jan 1, 2019 Mar 31, 2019
Q4 2018 -81.4 -5.69 -7.51% Oct 1, 2018 Dec 31, 2018
Q3 2018 -67.4 +13 +16.1% Jul 1, 2018 Sep 30, 2018
Q2 2018 -55.6 Apr 1, 2018 Jun 30, 2018
Q1 2018 -46.8 Jan 1, 2018 Mar 31, 2018
Q4 2017 -75.7 Oct 1, 2017 Dec 31, 2017
Q3 2017 -80.3 Jul 1, 2017 Sep 30, 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.